Detalles de la búsqueda
1.
Prognostic and predictive impact of metastatic organ involvement on maintenance therapy in advanced metastatic colorectal cancer: Subgroup analysis of patients treated within the PanaMa trial (AIO KRK 0212).
Int J Cancer
; 154(5): 863-872, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37840339
2.
Quality of life in pre- and postmenopausal patients with early breast cancer: a comprehensive analysis from the prospective MaLife project.
Breast Cancer Res Treat
; 175(3): 701-712, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30868393
3.
A randomized phase II study of paclitaxel alone versus paclitaxel plus sorafenib in second- and third-line treatment of patients with HER2-negative metastatic breast cancer (PASO).
BMC Cancer
; 17(1): 499, 2017 Jul 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-28743247
4.
Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial.
Lancet Oncol
; 16(13): 1355-69, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26361971
5.
Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial.
Lancet Oncol
; 15(8): 819-28, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24852116
6.
Dose escalating study of cetuximab and 5-FU/folinic acid (FA)/oxaliplatin/irinotecan (FOLFOXIRI) in first line therapy of patients with metastatic colorectal cancer.
BMC Cancer
; 14: 521, 2014 Jul 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-25038824
7.
Negative Hyperselection of Resistance Mutations for Panitumumab Maintenance in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa Phase II Trial, AIO KRK 0212).
Clin Cancer Res
; 30(7): 1256-1263, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38289994
8.
Phase I study of matuzumab in combination with 5-fluorouracil, leucovorin and cisplatin (PLF) in patients with advanced gastric and esophagogastric adenocarcinomas.
Invest New Drugs
; 31(3): 642-52, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22763610
9.
Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junction.
BMC Cancer
; 13: 75, 2013 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-23394629
10.
Optimal maintenance strategy following FOLFOX plus anti-EGFR induction therapy in patients with RAS wild type metastatic colorectal cancer: An individual patient data pooled analysis of randomised clinical trials.
Eur J Cancer
; 190: 112945, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37441940
11.
Depth of response of induction therapy and consecutive maintenance treatment in patients with RAS wild-type metastatic colorectal cancer: An analysis of the PanaMa trial (AIO KRK 0212).
Eur J Cancer
; 178: 37-48, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36399909
12.
Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab as maintenance therapy: a prespecified secondary analysis of the PanaMa (AIO KRK 0212) trial.
Eur J Cancer
; 190: 112955, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37454537
13.
Consensus Molecular Subtypes as Biomarkers of Fluorouracil and Folinic Acid Maintenance Therapy With or Without Panitumumab in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa, AIO KRK 0212).
J Clin Oncol
; 41(16): 2975-2987, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37018649
14.
Tumor vessel stabilization and remodeling by anti-angiogenic therapy with bevacizumab.
Histochem Cell Biol
; 137(3): 391-401, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22193946
15.
Phase I open-label study of cediranib, an oral inhibitor of VEGF signalling, in combination with the oral Src inhibitor saracatinib in patients with advanced solid tumours.
Invest New Drugs
; 30(5): 1962-71, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21989836
16.
Ten-year survival of esophageal cancer after an en-bloc esophagectomy.
J Surg Oncol
; 105(3): 284-7, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21953648
17.
Panitumumab Plus Fluorouracil and Folinic Acid Versus Fluorouracil and Folinic Acid Alone as Maintenance Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Randomized PANAMA Trial (AIO KRK 0212).
J Clin Oncol
; 40(1): 72-82, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34533973
18.
Cancer patients and the Internet: a survey of the 'Quality of Life' Working Groups of the Arbeitsgemeinschaft für Internistische Onkologie and the Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie.
Onkologie
; 34(8-9): 435-40, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21934343
19.
[Adjuvant therapy in colon cancer]. / Adjuvante therapie des kolonkarzinoms.
Onkologie
; 33 Suppl 4: 2-7, 2010.
Artículo
en Alemán
| MEDLINE | ID: mdl-20431306
20.
Gefitinib in combination with capecitabine as second-line therapy in patients with advanced colorectal cancer (aCRC): a phase I/II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
Onkologie
; 33(3): 89-93, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20215798